FrancophonIA/ELRC3.0 huggingface dataset:
English: Size 2 hard capsule (6.4x18.0 mm) with an opaque blue cap and opaque white body with “A1001” printed in black, containing white to pale brown powder.
Danish: Hårde kapsler, størrelse 2 (6,4 x 18,0 mm), med uigennemsigtig blå overdel og uigennemsigtig hvid underdel, der er mærket "A1001"med sort prægeblæk og indeholder hvidt til blegbrunt pulver.
English: What Galafold contains - The active substance is migalastat.
Danish: Galafold indeholder: - Aktivt stof: migalastat.
English: Disease Substrate
Danish: Substrat for sygdommen
English: After an average of 3.4 years of treatment, the mean annualised rate of change in eGFRCKD-EPI was -0.74 mL/min/1.73 m
Danish: Efter gennemsnitligt 3,4 års behandling var den gennemsnitlige annualiserede ændringsrate i eGFRCKD-EPI -0,74 ml/min/1,73 m
English: Protein Sequence change c.1A>C or c.1A>T
Danish: Ændring i proteinsekvens c.1A>C eller c.1A>T
English: Transient and fully reversible infertility in male rats was associated with migalastat treatment at all doses assessed.
Danish: Hos hanrotter er iagttaget forbigående og fuldt reversibel infertilitet ved behandling med migalastat i alle de undersøgte doser.
English: PRESS and hold tab at the left 2.
Danish: TRYK tappen i venstre side og hold den inde 2.
English: c.A1C or c.A1T
Danish: c.A1C eller c.A1T
English: Do not cut, crush, or chew the capsule.
Danish: Du må ikke skære kapslen over eller knuse eller tygge den.
English: If you are pregnant, think you may be pregnant, or are planning to have a baby, do not take this medicine until you have checked with your doctor, pharmacist, or nurse.
Danish: Hvis du er gravid, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal du spørge din læge, apotekspersonalet eller sundhedspersonalet til råds, før du tager dette lægemiddel.
English: c.559_564dup c.559_564dup p.M187_S188dup
Danish: Ændring i proteinsekvens c.559_564dup c.559_564dup p.M187_S188dup
English: Mean annualised rate of change in eGFRCKD-EPI was -0.40 mL/min/1.73 m
Danish: Den gennemsnitlige annualiserede ændringsrate i eGFRCKD-EPI var -0,40 ml/min/1,73 m
English: Galafold is not intended for concomitant use with enzyme replacement therapy (see section 4.4).
Danish: Galafold er ikke beregnet til anvendelse sammen med enzymsubstitutionsterapi (se pkt.
English: Patients randomised to Galafold in Stage 1 demonstrated statistically significant greater reduction (±SEM) in mean interstitial capillary GL-3 deposition (-0.25±0.10; -39%) at month 6 compared to placebo (+0.07 ± 0.13; +14%) (p=0.008).
Danish: De patienter, der i trin 1 blev randomiseret til Galafold, udviste en statistisk signifikant større reduktion (±SEM) i den gennemsnitlige aflejring af GL-3 i de interstitielle kapillærer (-0,25±0,10; -39 %) i måned 6 sammenlignet med patienter, der fik placebo (+0,07 ± 0,13; +14 %; p=0,008).
English: Blood Creatine Phosphokinase increased
Danish: Forhøjet kreatinkinase i blodet Vægtstigning
English: Galafold is not intended for concomitant use with enzyme replacement therapy.
Danish: Galafold er ikke beregnet til administration sammen med enzymsubstitutionsterapi.
English: c.1018T>C or c.1018T>A c.T1018C or c.T1018A
Danish: c.1018T>C eller c.1018T>A c.T1018C eller c.T1018A
English: Once in lysosomes dissociation of migalastat restores -Gal A activity, leading to the catabolism of GL-3 and related substrates.
Danish: Når -Gal A-aktiviteten i lyosomer genetableres ved fraspaltning af migalastat, medfører det katabolisering af GL-3 og beslægtede glykosfingolipider.
English: Torticollis Pain in extremity
Danish: Smerter i ekstremitet
English: This enzyme defect leads to abnormal deposits of a fatty substance known as globotriaosylceramide (GL-3) in kidneys, heart, and other organs, leading to the symptoms of Fabry disease.
Danish: Denne enzymdefekt medfører abnorme aflejringer af fedtstoffet globotriaosylceramid (GL-3) i nyrerne, hjertet og andre organer.
English: (dyspnoea)
Danish: (dyspepsi)
English: c.G611A or G612A
Danish: c.G611A eller G612A
English: c.369+3_639+954del3129insT UNKNOWN (del Exon3 and 4?)
Danish: c.369+3_639+954del3129insT UKENDT (del Exon3 og g.6009_9741del
English: • Reduced sense of touch or sensation
Danish: • Nedsat følsomhed ved berøring (hypæstesi)
English: To access the package leaflet, scan the code below.
Danish: Scan koden nedenfor for at få adgang til indlægssedlen.
English: Always take this medicine exactly as your doctor, pharmacist, or nurse has told you.
Danish: Tag altid lægemidlet nøjagtigt efter lægens, apotekspersonalets eller sundhedspersonalets anvisning.
English: How to take Galafold
Danish: Sådan skal du tage Galafold
English: c.140G>A or 141G>A
Danish: c.140G>A eller 141G>A
English: In the ERT-naïve trial, Galafold resulted in a statistically significant decrease in LVMi (p< 0.05); the mean change from baseline in LVMi at Month 18 to 24 was -7.7 (95% CI: -15.4, -0.01; n=27).
Danish: I forsøget med ERT-naive patienter medførte Galafold en statistisk signifikant mindskelse i LVMi (p< 0,05); den gennemsnitlige ændring fra baseline i LVMi ved måned 18 til 24 var -7,7 (95 % CI:-15,4; -0,01; n=27).
English: g.2594_10904dup c.195-2500_999+197dup
Danish: g.2594_10904dup c.195-2500_999+197dup g.2934_6378del
English: In the absence of similar findings in females, no findings in the genotoxicity battery or in the carcinogenicity study with Tg.rasH2 mice, and no pre-neoplastic pancreatic findings in the rodents or monkeys, this observation in male rats is not considered related to treatment and its relevance to humans is unknown.
Danish: Denne iagttagelse hos hanrotter anses ikke for at være behandlingsrelateret pga. fravær af tilsvarende fund hos hundyr og fravær af fund i et batteri af genotoksicitetsstudier og i karcinogenicitetsstudiet hos Tg.rasH2-mus samt fravær af præneoplastiske fund i pancreas hos gnavere og aber.
English: g.6736_11545del c.370-533_c.1290+277del
Danish: UKENDT (del Exon3 og g.6736_11545del c.370-533_c.1290+277del
English: c.T1147C or c.C1149G or c.C1149A
Danish: c.T1147C eller c.C1149G eller c.C1149A
English: Migalastat did not affect fertility in female rats.
Danish: Migalastat havde ingen indvirkning på fertiliteten hos hunrotter.
English: • Indigestion (dyspepsia)
Danish: • Åndenød (dyspnø)
English: c.611G>A or 612G>A
Danish: c.611G>A eller 612G>A
English: c.A504C or c.A504T
Danish: c.A504C eller c.A504T
English: If more than 12 hours has passed you should resume taking Galafold at the next planned dosing day and time according to your every other day dosing schedule.. Do not take two capsules to make up for your missed dose.
Danish: Hvis der er gået mere end 12 timer, skal du genoptage behandlingen med Galafold på næste planlagte doseringsdag og -tidspunkt i henhold til din plan med dosering hver anden dag.
English: c.712A>C or c.714T>A or c.714T>G
Danish: c.712A>C eller c.714T>A eller c.714T>G
English: Check with your doctor, pharmacist, or nurse if you are not sure.
Danish: Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, du er i tvivl om.
English: g.10237_11932del/11933_12083i nv/12084_12097del
Danish: g.10237_11932del/11933_12083i nv/12084_12097del g.>5.5kbdel tis 3UTR
English: c.442A>C or c.444T>A or c.444T>G
Danish: c.442A>C eller c.444T>A eller c.444T>G
English: C]-migalastat hydrochloride revealed that approximately 77% of the radiolabeled dose was recovered in urine of which 55% of was excreted as unchanged migalastat and 4% as combined metabolites M1, M2 and M3.
Danish: I et farmakokinetisk forsøg hos raske mandlige forsøgspersoner, der fik 150 mg C]-migalastathydrochlorid blev ca. 77 % af den radioaktivt mærkede dosis genfundet i urinen, hvoraf 55 % blev udskilt som uomdannet migalastat og 4 % som kombinerede metabolitter M1, M2 og M3. 5 % af den samlede prøveradioaktivitet var ubestemte komponenter.
English: c.A924T or c.A924C
Danish: c.A924T eller c.A924C
English: (proteinuria)
Danish: (proteinuri)
English: c.G140A or G141A
Danish: c.G140A eller G141A
English: c.504A>C or c.504A>T
Danish: c.504A>C eller c.504A>T
English: c.924A>T or c.924A>C
Danish: c.924A>T eller c.924A>C
English: Galafold is not recommended for use in patients with Fabry disease who have estimated GFR less than 30 mL/min/1.73 m
Danish: Galafold frarådes anvendt hos patienter med Fabrys sygdom, som har en estimeret GFR under 30 ml/min/1,73 m
English: c.T148C or c.C150G or c.C150A F50L
Danish: c.T148C eller c.C150G eller c.C150A
English: c.G412A or c.G412C
Danish: c.G412A eller c.G412C
English: During the first period (18-months) ERT-experienced patients were randomised to switch from ERT to Galafold or continue with ERT.
Danish: Under den første periode (18 måneder) blev ERT-erfarne patienter randomiseret til at skifte fra ERT til Galafold eller fortsætte med ERT. Anden periode var en valgfri 12 måneders ikke-blindet forlængelse, hvor alle forsøgspersoner fik Galafold.
English: The mean change from baseline in LVMi at Month 18 to 24 in patients with left ventricular hypertrophy at baseline (females with baseline LVMi > 95 g/m or males with baseline LVMi > 115 g/m 2) was -18.6 (95% CI: -38.2, 1.0; n=8).
Danish: Gennemsnitsændringen fra baseline i LVMi ved måned 18 til 24 hos patienter med hypertrofi af venstre ventrikel ved baseline (baseline-LVMi > 95 g/m2 for kvinder og baseline-LVMi > 115 g/m for mænd) var -18,6 (95 % CI: -38,2; 1,0; n=8).
English: c.1147T>C or c.1149C>G or c.1149C>A
Danish: c.1147T>C eller c.1149C>G eller c.1149C>A
English: c.561G>T or c.561G>A or c.561G>C
Danish: c.561G>T eller c.561G>A eller c.561G>C
English: • Sudden need to defecate
Danish: • Pludselig trang til afføring
English: Similar findings have been noted pre-clinically following treatment with other iminosugars.
Danish: Tilsvarende er fundet efter behandling med andre iminosukkerarter præklinisk.
English: Galafold is not recommended for use in patients with severe renal insufficiency, defined as estimated GFR less than 30 mL/min/1.73m
Danish: Galafold frarådes til patienter med svær nyreinsufficiens, defineret som estimeret GFR under 30 ml/min/1,73 m
English: After follow up in the OLE, the mean change from baseline in LVMi at Month 36 was -8.3 (95% CI: -17.1, 0.4; n=25) and at Month 48 was -9.1 (95% CI: -20.3, 2.0; n=18).
Danish: Efter opfølgning i det åbne forlængelsesforsøg var gennemsnitsændringen fra baseline i LVMi ved måned 36 -8,3 (95 % CI: -17,1; 0,4; n=25) og var ved måned 48 -9,1 (95 % CI: -20,3; 2,0; n=18).
English: c.A124C or c.A124T
Danish: c.A124C eller c.A124T
English: c.70T>C or c.70T>A
Danish: c.70T>C eller c.70T>A
English: c.280T>A or c.281G>C
Danish: c.280T>A eller c.281G>C
English: c.1045T>C or c.1045T>A c.T1045C or c.T1045A
Danish: c.1045T>C eller c.1045T>A c.T1045C eller c.T1045A
English: c.T187A or c.G188C
Danish: c.T187A eller c.G188C
English: c.1095T>A or c.1095T>G c.T1095A or c.T1095G
Danish: c.1095T>A eller c.1095T>G c.T1095A eller c.T1095G
English: c.216G>A or c.216G>T or c.216G>C
Danish: c.216G>A eller c.216G>T eller c.216G>C
English: c.G982A or c.G982C
Danish: c.G982A eller c.G982C
English: If you are planning to have a baby, ask your doctor, pharmacist, or nurse for advice.
Danish: Hvis du planlægger at blive gravid, skal du spørge lægen, apotekspersonalet eller sundhedspersonalet til råds.
English: c.817T>C or c.819T>A or c.819T>G
Danish: c.817T>C eller c.819T>A eller c.819T>G
English: c.337T>C or c.339T>A or c.339T>G
Danish: c.337T>C eller c.339T>A eller c.339T>G
English: c.412G>A or c.412G>C
Danish: c.412G>A eller c.412G>C
English: c.G285T or c.G285C
Danish: c.G285T eller c.G285C
English: c.71G>A or c.72G>A
Danish: c.71G>A eller c.72G>A
English: Protein Sequence change c.290delC
Danish: Ændring i proteinsekvens c.270delC
English: c.T70C or c.T70A
Danish: c.T70C eller c.T70A
English: c.982G>A or c.982G>C
Danish: c.982G>A eller c.982G>C
English: c.228G>C or c.228G>A or c.228G>T
Danish: c.228G>C eller c.228G>A eller c.228G>T
English: c.G540C or c.G540T
Danish: c.G540C eller c.G540T
English: c.G471C or c.G471T
Danish: c.G471C eller c.G471T
English: c.T166A or c.G167C
Danish: c.T166A eller c.G167C
English: c.G261C or c.G261T
Danish: c.G261C eller c.G261T
English: c.612G>T or c.612G>C
Danish: c.612G>T eller c.612G>C
English: c.G71A or c.G72A
Danish: c.G71A eller c.G72A
English: c.187T>A or c.188G>C
Danish: c.187T>A eller c.188G>C
English: c.261G>C or c.261G>T
Danish: c.261G>C eller c.261G>T
English: c.124A>C or c.124A>T
Danish: c.124A>C eller c.124A>T
English: c.G612T or c.G612C
Danish: c.G612T eller c.G612C
English: c.285G>T or c.285G>C
Danish: c.285G>T eller c.285G>C
English: c.471G>C or c.471G>T
Danish: c.471G>C eller c.471G>T
English: c.G132T or c.G132C
Danish: c.G132T eller c.G132C
English: c.T514A or c.G515C
Danish: c.T514A eller c.G515C
English: c.G243T or c.G243C
Danish: c.G243T eller c.G243C
English: c.T280A or c.G281C
Danish: c.T280A eller c.G281C
English: UNKNOWN (del Exon3?)
Danish: UKENDT (del Exon3?)
English: c.G609C or c.G609T
Danish: c.G609C eller c.G609T
English: c.166T>A or c.167G>C
Danish: c.166T>A eller c.167G>C
English: c.609G>C or c.609G>T
Danish: c.609G>C eller c.609G>T
English: c.G144T or c.G144C
Danish: c.G144T eller c.G144C
English: c.T784A or c.T784C
Danish: c.T784A eller c.T784C
English: c.243G>T or c.243G>C
Danish: c.243G>T eller c.243G>C
English: c.A840T or c.A840C
Danish: c.A840T eller c.A840C
English: c.132G>T or c.132G>C
Danish: c.132G>T eller c.132G>C
English: c.G567C or c.G567T
Danish: c.G567C eller c.G567T
English: c.144G>T or c.144G>C
Danish: c.144G>T eller c.144G>C
English: c.540G>C or c.540G>T
Danish: c.540G>C eller c.540G>T
English: c.T154A or c.G155C
Danish: c.T154A eller c.G155C
English: UNKNOWN (del Exon1_2?)
Danish: UKENDT (del Exon1_2?)
English: BLISTER FOIL
Danish: BLISTERKORT
English: c.A588T or c.A588C
Danish: c.A588T eller c.A588C
English: c.G831T or c.G831C
Danish: c.G831T eller c.G831C
English: c.G141C or c.G141T
Danish: c.G141C eller c.G141T
English: c.567G>C or c.567G>T
Danish: c.567G>C eller c.567G>T
English: c.108G>C or c.108G>T
Danish: c.108G>C eller c.108G>T
English: UNKNOWN (del Exon5_7?)
Danish: UKENDT (del Exon5_7?)
English: c.141G>C or c.141G>T
Danish: c.141G>C eller c.141G>T
English: See package leaflet for further instructions.
Danish: Yderligere oplysninger fremgår af indlægssedlen.
English: c.831G>T or c.831G>C
Danish: c.831G>T eller c.831G>C
English: c.784T>A or c.784T>C
Danish: c.784T>A eller c.784T>C
English: Protein Sequence change c.1202C>G or c.1202C>A c.C1202G or c.C1202A
Danish: W399S c.1202C>G eller c.1202C>A c.C1202G eller c.C1202A S401X c.1215T>A
English: c.154T>A or c.155G>C
Danish: c.154T>A eller c.155G>C
English: c.T667A or c.G668C
Danish: c.T667A eller c.G668C
English: c.G439A or c.G439C
Danish: c.G439A eller c.G439C
English: In a single dose study with Galafold in non-Fabry subjects with varying degrees of renal insufficiency, exposures were increased by 4.3-fold in subjects with severe renal impairment (GFR < 30 mL/min/1.73 m
Danish: Patienter med nedsat nyrefunktion Galafold er ikke undersøgt hos Fabry-patienter med GFR under 30 ml/min/1,73 m2. I et enkeltdosisstudie med Galafold hos personer uden Fabrys sygdom, men med forskellige grader af nyreinsufficiens var eksponeringen øget med en faktor 4,3 hos personer med svært nedsat nyrefunktion (GFR < 30 ml/min/1,73 m
English: c.963G>C or c.963G>T
Danish: c.963G>C eller c.963G>T
English: c.514T>A or c.515G>C
Danish: c.514T>A eller c.515G>C
English: c.G216A or c.G216T or c.G216C M72I
Danish: c.G216A eller c.G216T eller c.G216C
English: c.G108C or c.G108T
Danish: c.G108C eller c.G108T
English: Paraesthesia Dizziness Hypoaesthesia
Danish: Paræstesi Svimmelhed Hypæstesi
English: c.T817C or c.T819A or c.T819G F273L
Danish: c.T817C eller c.T819A eller c.T819G
English: c.G394A or c.G394C
Danish: c.G394A eller c.G394C
English: c.439G>A or c.439G>C
Danish: c.439G>A eller c.439G>C
English: c.870G>A or c.870G>C or c.870G>T
Danish: c.870G>A eller c.870G>C eller c.870G>T
English: c.G861C or c.G861T
Danish: c.G861C eller c.G861T
English: c.888G>A or c.888G>T or c.888G>C
Danish: c.888G>A eller c.888G>T eller c.888G>C
English: (95% CI: -3.636, 1.575; n=18) in the ERT group.
Danish: (95 % CI: -2,272; 1,478; n=34) i Galafold-gruppen versus -1,03 ml/min/1,73 m (95 % CI: -3,636; 1,575; n=18) i ERT-gruppen.
English: c.T337C or c.T339A or c.T339G F113L
Danish: c.T337C eller c.T339A eller c.T339G
English: c.394G>A or c.394G>C
Danish: c.394G>A eller c.394G>C
English: c.G486C or c.G486T
Danish: c.G486C eller c.G486T
English: c.G936T or c.G936C
Danish: c.G936T eller c.G936C
English: c.G837C or c.G837T
Danish: c.G837C eller c.G837T
English: c.708G>C or c.708G>T
Danish: c.708G>C eller c.708G>T
English: Hepatic impairment No dosage adjustment of Galafold is required in patients with hepatic impairment (see section 5.2).
Danish: Nedsat leverfunktion Justering af Galafold-dosis er ikke nødvendig på grund af nedsat leverfunktion (se pkt.
English: c.840A>T or c.840A>C
Danish: c.840A>T eller c.840A>C
English: c.588A>T or c.588A>C
Danish: c.588A>T eller c.588A>C
English: c.A868C or c.A868T
Danish: c.A868C eller c.A868T
English: c.G963C or c.G963T
Danish: c.G963C eller c.G963T
English: c.861G>C or c.861G>T
Danish: c.861G>C eller c.861G>T
English: Galafold 123 mg hard capsules migalastat
Danish: Galafold 123 mg kapsler, hårde migalastat
English: c.G126A or c.G126C or c.G126T M42I
Danish: c.G126A eller c.G126C eller c.G126T
English: The change from baseline to Month 18 in LVMi (g/m 2) in patients with left ventricular hypertrophy (females with baseline LVMi > 95 g/m and males with baseline LVMi > 115 g/m2) was -8.4 (95% CI: -15.7, 2.6; n=13) for migalastat and 4.5 (95% CI: -10.7, 18.4; n=5) for ERT. After 30 months treatment with Galafold, the mean change from baseline in LVMi was -3.8 (95% CI: -8.9, 1.3; n=28) and the mean change from baseline in LVMi in patients with left ventricular hypertrophy at baseline was -10.0 (95% CI: -16.6, -3.3; n=10).
Danish: 92,9 g/m for ERT-gruppen, og den gennemsnitlige ændring fra baseline i LVMi ved måned 18 var - 6,6 (95 % CI: -11,0; -2,1; n=31) for Galafold og -2,0 (95 % CI: -11,0; 7,0; n=13) for ERT. Ændringen i LVMi (g/m2) fra baseline til måned 18 hos patienter med hypertrofi af venstre ventrikel (baseline-LVMi > 95 g/m for kvinder og baseline-LVMi > 115 g/m for mænd) var -8,4 (95 % CI: -15,7; 2.6; n=13) for migalastat og 4,5 (95 % CI: -10,7; 18,4; n=5) for ERT.
English: c.837G>C or c.837G>T
Danish: c.837G>C eller c.837G>T
English: c.72G>C or c.72G>T
Danish: c.72G>C eller c.72G>T
English: c.A712C or c.T714A or c.T714G S238R
Danish: c.A712C eller c.T714A eller c.T714G
English: c.667T>A or c.668G>C
Danish: c.667T>A eller c.668G>C
English: UNKNOWN (del Exon3_7?)
Danish: UKENDT (del Exon3_7?)
English: c.1019G>A or c.1020G>A c.G1019A or c.G1020A
Danish: W340R c.1019G>A eller c.1020G>A c.G1019A eller c.G1020A W340X c.1019G>C
English: c.978G>C or c.978G>T
Danish: c.978G>C eller c.978G>T
English: c.288G>A or c.288G>T or c.288G>C
Danish: c.288G>A eller c.288G>T eller c.288G>C
English: The mean annualised rate of change from baseline in eGFRCKD-EPI in patients treated for 30 months with Galafold was -1.72 mL/min/1.73 m
Danish: Den gennemsnitlige annualiserede ændringsrate i eGFRCKD-EPI hos patienter, der blev behandlet i 30 måneder med Galafold, var -1,72 ml/min/1,73 m (95 % CI: -2,653; -0,782; n=31).
English: c.486G>C or c.486G>T
Danish: c.486G>C eller c.486G>T
English: If you take more Galafold than you should
Danish: Hvis du har taget for meget Galafold
English: c.G228C or c.G228A or c.G228T M76I
Danish: c.G228C eller c.G228A eller c.G228T
English: c.148T>C or c.150C>G or c.150C>A
Danish: Ændring i proteinsekvens c.148T>C eller c.150C>G eller c.150C>A
English: Protein Sequence change c.744delT
Danish: Ændring i proteinsekvens c.741ins9
English: c.720G>C or c.720G>T
Danish: c.720G>C eller c.720G>T
English: c.678G>T or c.678G>C
Danish: c.678G>T eller c.678G>C
English: c.G978C or c.G978T
Danish: c.G978C eller c.G978T
English: UNKNOWN (del Exon2_3?)
Danish: UKENDT (del Exon2_3?)
English: c.C525G or c.C525A
Danish: c.525C>G eller c.525C>A c.C525G eller c.C525A
English: • Painful stiff neck
Danish: • Smertefuld nakkestivhed
English: While taking Galafold you should use effective birth control.
Danish: Du skal bruge effektiv prævention, mens du er i behandling med Galafold.
English: c.729G>C or c.729G>T
Danish: c.729G>C eller c.729G>T
English: c.G720C or c.G720T
Danish: c.G720C eller c.G720T
English: c.G72C or c.G72T
Danish: c.G72C eller c.G72T
English: c.G729C or c.G729T
Danish: c.G729C eller c.G729T
English: c.G708C or c.G708T
Danish: c.G708C eller c.G708T
English: c.868A>C or c.868A>T
Danish: c.868A>C eller c.868A>T
English: c.C159G or c.C159A
Danish: c.159C>G eller c.159C>A c.C159G eller c.C159A
English: c.G153A or c.G153T or c.G153C M51I
Danish: c.G153A eller c.G153T eller c.G153C
English: c.C279G or c.C279A
Danish: c.279C>G eller c.279C>A c.C279G eller c.C279A
English: c.G678T or c.G678C
Danish: c.G678T eller c.G678C
English: c.G561T or c.G561A or c.G561C M187I
Danish: c.G561T eller c.G561A eller c.G561C
English: c.A886T or c.A886C
Danish: c.A886T eller c.A886C
English: c.A442C or c.T444A or c.T444G S148R
Danish: c.A442C eller c.T444A eller c.T444G
English: • Stomach ache
Danish: Dyspnø Epistaxis
English: c.G870A or c.G870C or c.G870T M290I
Danish: c.G870A eller c.G870C eller c.G870T
English: c.G786C or c.G786T
Danish: c.G786C eller c.G786T
English: c.886A>T or c.886A>C
Danish: c.886A>T eller c.886A>C
English: c.G888A or c.G888T or c.G888C M296I
Danish: c.G888A eller c.G888T eller c.G888C
English: c.786G>C or c.786G>T
Danish: c.786G>C eller c.786G>T
English: Protein Sequence change p.T412Sfs*37
Danish: p.T412Sfs*37
English: Protein sequence change c.126G>A or c.126G>C or c.126G>T
Danish: c.126G>A eller c.126G>C eller c.126G>T
English: • Palpitations (the feeling of a pounding heart)
Danish: • Hjertebanken (palpitationer)
English: c.207C>A or c.207C>G
Danish: c.207C>A eller c.207C>G c.C207A eller c.C207G
English: c.G288A or c.G288T or c.G288C M96I
Danish: c.G288A eller c.G288T eller c.G288C
English: c.T139C or c.T139A
Danish: c.139T>C eller c.139T>A c.T139C eller c.T139A
English: c.552T>A or c.552T>G
Danish: c.552T>A eller c.552T>G c.T552A eller c.T552G
English: c.1023A >C or c.1023A>T
Danish: c.1023A >C eller c.1023A>T c.A1023C eller c.A1023T
English: galafold 123 mg hard capsules
Danish: Galafold 123 mg kapsler, hårde
English: Fatigue Pain
Danish: Træthed Smerter
English: Abdominal pain Constipation Dry mouth
Danish: Abdominalsmerter Obstipation Mundtørhed Defækationstrang Dyspepsi
English: c.1034C>G or c.1034C>A c.C1034G or c.C1034A
Danish: L344P c.1034C>G eller c.1034C>A c.C1034G eller c.C1034A S345X c.1042G>C
English: c.1196G>A or c.1197G>A c.G1196A or c.G1197A
Danish: Ændring i proteinsekvens c.1196G>A eller c.1197G>A c.G1196A eller c.G1197A W399X c.1196G>C
English: c.C305G or c.C305A
Danish: c.305C>G eller c.305C>A c.C305G eller c.C305A
English: Table 2: Galafold (migalastat) amenability table
Danish: Tabel 2: GLA-mutationer, der kan behandles med Galafold (migalastat)
English: Galafold 123 mg hard capsules
Danish: Galafold hårde kapsler 123 mg
English: c.C747G or c.C747A
Danish: c.747C>G eller c.747C>A c.C747G eller c.C747A
English: c.T258G or c.T258A
Danish: c.258T>G eller c.258T>A c.T258G eller c.T258A
English: c.G284A or c.G285A
Danish: c.284G>A eller c.285G>A c.G284A eller c.G285A
English: c.1046G>A or c.1047G>A c.G1046A or c.G1047A
Danish: W349R c.1046G>A eller c.1047G>A c.G1046A eller c.G1047A W349X c.1048G>C
English: c.816C>A or c.816C>G
Danish: c.816C>A eller c.816C>G c.C816A eller c.C816G
English: c.519C>A or c.519C>G
Danish: c.519C>A eller c.519C>G c.C519A eller c.C519G
English: c.1081G>A or c.1081G>C
Danish: c.1081G>A eller c.1081G>C c.G1081A eller c.G1081C
English: c.C897G or c.C897A
Danish: c.897C>G eller c.897C>A c.C897G eller c.C897A
English: c.T241C or c.T241A
Danish: c.241T>C eller c.241T>A c.T241C eller c.T241A
English: c.830G>A or c.831G>A
Danish: c.830G>A eller c.831G>A c.G830A eller c.G831A
English: c.785G>A or c.786G>A
Danish: c.785G>A eller c.786G>A c.G785A eller c.G786A
English: c.T706C or c.T706A
Danish: c.706T>C eller c.706T>A c.T706C eller c.T706A
English: c.G485A or c.G486A
Danish: c.485G>A eller c.486G>A c.G485A eller c.G486A
English: c.T859C or c.T859A
Danish: c.859T>C eller c.859T>A c.T859C eller c.T859A